| Autor: |
Guerrero J; 1 Inserm, U1026, Tissue Bioengineering, University of Bordeaux , Bordeaux, France ., Oliveira H, Catros S, Siadous R, Derkaoui SM, Bareille R, Letourneur D, Amédée J |
| Jazyk: |
angličtina |
| Zdroj: |
Tissue engineering. Part A [Tissue Eng Part A] 2015 Mar; Vol. 21 (5-6), pp. 861-74. Date of Electronic Publication: 2014 Dec 01. |
| DOI: |
10.1089/ten.TEA.2014.0367 |
| Abstrakt: |
Current approaches in bone tissue engineering have shown limited success, mostly owing to insufficient vascularization of the construct. A common approach consists of co-culture of endothelial cells and osteoblastic cells. This strategy uses cells from different sources and differentiation states, thus increasing the complexity upstream of a clinical application. The source of reparative cells is paramount for the success of bone tissue engineering applications. In this context, stem cells obtained from human bone marrow hold much promise. Here, we analyzed the potential of human whole bone marrow cells directly expanded in a three-dimensional (3D) polymer matrix and focused on the further characterization of this heterogeneous population and on their ability to promote angiogenesis and osteogenesis, both in vitro and in vivo, in a subcutaneous model. Cellular aggregates were formed within 24 h and over the 12-day culture period expressed endothelial and bone-specific markers and a specific junctional protein. Ectopic implantation of the tissue-engineered constructs revealed osteoid tissue and vessel formation both at the periphery and within the implant. This work sheds light on the potential clinical use of human whole bone marrow for bone regeneration strategies, focusing on a simplified approach to develop a direct 3D culture without two-dimensional isolation or expansion. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
